Galderma Successfully Completes Acquisition of ALASTIN Skincare
Galderma announces that it has received antitrust clearance from the US authorities and has completed the acquisition of ALASTIN Skincare Inc.
Galderma announces that it has received antitrust clearance from the US authorities and has completed the acquisition of ALASTIN Skincare Inc.
The ready-to-use liquid botulinum toxin treatment requires no reconstitution. Phase III trials showed improvements in frown lines, with some patients maintaining results for up to six months.